(Q35105709)

6 August 2017

1 reference

title

Current therapy for hepatitis C: pegylated interferon and ribavirin (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691464

23 December 2023

author name string

John G. McHutchison

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691464

23 December 2023

Michael W. Fried

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691464

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691464

23 December 2023

publication date

1 February 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S1089326102000776?httpAccept=text/xml

1 reference

10.1016/S1089-3261(02)00077-6

DOI

https://api.crossref.org/works/10.1016/S1089-3261(02)00077-6

https://api.elsevier.com/content/article/PII:S1089326102000776?httpAccept=text/plain

23 December 2023

1 reference

10.1016/S1089-3261(02)00077-6

DOI

https://api.crossref.org/works/10.1016/S1089-3261(02)00077-6

23 December 2023

published in

Clinics in liver disease

1 reference

6 August 2017

7

1 reference

6 August 2017

149-161

1 reference

6 August 2017

1

1 reference

Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Standardization of hepatitis C virus RNA quantification

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900077-6

7 January 2021

10.1016/S1089-3261(02)00077-6

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/to65mcuhdzhtthvvxmquhfvita

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_to65mcuhdzhtthvvxmquhfvita

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/to65mcuhdzhtthvvxmquhfvita

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/to65mcuhdzhtthvvxmquhfvita

30 July 2022